The list is maintained by Raymond L. Woosley, MD, PhD, President, AZCERT and SADS Scientific Advisor.
The following two changes have been made to the lists:
Added to "Possible risk of torsades de pointes":
Added to "Risk of torsades de pointes".
Drugs are listed with up to 2 common brand names. There are many more brand names for some of the common drugs, such as pseudoephedrine and erythromycin. It is also important to look at the list of active drugs in medicines that contain a combination of drugs such as Zyrtec-D®, which contains pseudoephedrine. This means that you must look up each ingredient of the drug to see if it is on this list.
The list is sorted into four groups based on the risk for people with LQTS. It is recommended that those with inherited long QT syndrome not take any of the drugs on these lists. It is also recommended that people with LQTS avoid any herbal medicines/remedies as these may contain ingredients that could cause an event.
BrugadaDrugs.org has been initiated by the University of Amsterdam Academic Medical Center, department of Cardiology, as an aid to physicians who treat patients with Brugada syndrome and as an aid to patients with Brugada syndrome.
Many drugs have been associated with the type-1 ECG and/or with arrhythmias in Brugada syndrome patients. We have divided these drugs into four lists (together with the available evidence in the literature and a recommendation from the BrugadaDrugs.org Advisory Board) :
COPYRIGHT ©2011-2015 Sudden Arrhythmia Death Syndromes Foundation
508 E. South Temple, Suite #202, Salt Lake City, UT 84102